FORW.PHARMA /14 ADR - Unternehmensdaten & Kurse - US34986J2042 | MoneyPeak

FORW.PHARMA ADR/14

Depository Receipt · US34986J2042 · FWP · A2PV5H (XNCM)

No Price

n/a

Company Profile for FORW.PHARMA ADR/14 Depository Receipt

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Get up to date insights from finAgent about FORW.PHARMA ADR/14

Company Data

Name FORW.PHARMA ADR/14

Company Forward Pharma A/S

Symbol FWP

Website https://www.forward-pharma.com

Primary Exchange

NASDAQ CAPITAL MARKET

WKN A2PV5H

ISIN US34986J2042

Asset Class Depository Receipt

Sector Healthcare

Industry Biotechnology

CEO Claus Svendsen

Country Denmark

Currency EUR

Employees 0,0 T

Address Oestergade 24A, 1, Copenhagen K, 1100 Koebenhavn K

IPO Date 2014-10-15

Ticker Symbols

Name	Symbol
NASDAQ	FWP

More Shares

Investors who hold FORW.PHARMA ADR/14 also have the following shares in their portfolio:

AGIF-A.GL.ART.INTEL.AT DL Fund

AMGEN INC Share

ASANA INC - CLASS A Share

AUTODESK INC Share

BNPPE-MSCI PA.XJXCW.UECEO ETF

CISCO SYSTEMS INC Share

CORBUS PHARMACEUTICALS HOLDINGS INC Share

COSTCO WHOLESALE CORP Share

DOLLAR TREE INC Share

INFINEON TECHNOLOGIESLOGIES AG Share

INTEL CORP Share

MICROSOFT CORP Share

WALGREENS BOOTS ALLIANCE INC Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025